Ran Li
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 32
- MicroRNA in disease regulation 18
- Epidemiology top 1%
- Biological Psychiatry top 2%
- Physiology top 1%
- Neurology top 1%
-
- RNA modifications and cancer 20
- RNA Research and Splicing 13
- Inflammasome and immune disorders 10
-
- Air Quality and Health Impacts 12
- Climate Change and Health Impacts 9
-
- Cell Adhesion Molecules Research 9
- Journals
- Scientific Reports (6 papers)International Journal of Molecular Sciences (5 papers)Medicine (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ran Li
296 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Cancer Research 1.2k
- Epidemiology 2.4k
- Biological Psychiatry 172
- Physiology 302
- Neurology 525
Countries citing papers authored by Ran Li
This map shows the geographic impact of Ran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Li more than expected).
Fields of papers citing papers by Ran Li
This network shows the impact of papers produced by Ran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Li. The network helps show where Ran Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 1 | |
| 15 | 2022 | 10 | |
| 16 | 2022 | 25 | |
| 17 | Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer | 2021 | 9 |
| 18 | 2016 | 78 | |
| 19 | 2016 | 133 | |
| 20 | 2005 | 38 |
About Ran Li
Ran Li is a scholar working on Cancer Research, Molecular Biology and Neurology, having authored 316 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (32 papers), RNA modifications and cancer (20 papers), MicroRNA in disease regulation (18 papers), RNA Research and Splicing (13 papers), Air Quality and Health Impacts (12 papers), Inflammasome and immune disorders (10 papers), Cell Adhesion Molecules Research (9 papers) and Climate Change and Health Impacts (9 papers). The work is most often cited by research in Cancer Research (1.2k citations), Epidemiology (2.4k citations) and Biological Psychiatry (172 citations). Ran Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Junling Gao, Yanxia Tian, Richard C. Wang, Pei Jiang, Feng Jin, Xiaohua Jiang, Ying Cui, Changmeng Cui, Keenan Sterling and Huaqiu Chen. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences, Medicine, PLoS ONE and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.